M. Cammarano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Cammarano has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alfredo Pontecorvi
Dipartimento di Medicina e chirurgia traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy
1 shared publication - Andrea Silvestrini
Dipartimento di Scienze della Salute e della Vita, Università Europea di Roma, 00163 Rome, Italy
1 shared publication - Antonio Mancini
Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00136 Rome, Italy
1 shared publication - Chantal Di Segni
Operative Unit of Endocrinology, Catholic University of the Sacred Heart, 00168 Rome, Italy
1 shared publication - Elisabetta Meucci
Institute of Biochemistry and Clinical Biochemistry, Catholic University of the Sacred Heart, Rome, Italy
1 shared publication - G. Gadotti
Division of Endocrinology, Department of Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 20 November 2013
- Published by Wiley in International Journal of Endocrinology
- Vol. 2013, 1-6
Estrogens as Antioxidant Modulators in Human Fertility
Among treatments proposed for idiopathic male infertility, antiestrogens, like tamoxifen, play a possible role. On the other hand, oxidative stress is a mechanism well recognized for deleterious effects on spermatozoa function. After reviewing the literature on the effects of estrogens in modulation of antioxidant systems, in both sexes, and in differentin vivoandin vitromodels, we suggest, also on the basis of personal data, that a tamoxifen treatment could be active via an increase in seminal antioxidants.
- 20 November 2013
- Published by Wiley in International Journal of Endocrinology
- Vol. 2013, 1-6
Open AccessEstrogens as Antioxidant Modulators in Human Fertility
Among treatments proposed for idiopathic male infertility, antiestrogens, like tamoxifen, play a possible role. On the other hand, oxidative stress is a mechanism well recognized for deleterious effects on spermatozoa function. After reviewing the literature on the effects of estrogens in modulation of antioxidant systems, in both sexes, and in differentin vivoandin vitromodels, we suggest, also on the basis of personal data, that a tamoxifen treatment could be active via an increase in seminal antioxidants.